Increased complication rates of cardiac rhythm management devices in ESRD patients.
暂无分享,去创建一个
R. Passman | J. Goldberger | D. Lloyd‐Jones | C. Ghossein | S. Medendorp | Arijit Dasgupta | J. Montalvo
[1] Rod Passman,et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. , 2006, Heart rhythm.
[2] D. Delurgio,et al. Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery , 2006, Pacing and clinical electrophysiology : PACE.
[3] A. Collins,et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. , 2005, Kidney international.
[4] H. Bonnemeier,et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity , 2005, Heart.
[5] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[6] P. McCullough,et al. Impact of Chronic Kidney Disease Upon Survival Among Implantable Cardioverter-Defibrillator Recipients , 2004, Journal of Interventional Cardiac Electrophysiology.
[7] H. Schunkert,et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. , 2004, Chest.
[8] J. Morrow,et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] G. Breithardt,et al. Mortality, Morbidity, and Complications in 3,344 Patients with Implantable Cardioverter Defibrillators: , 2003 .
[10] C. Herzog. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. , 2003, Kidney international. Supplement.
[11] F. Manian. Vascular and Cardiac Infections in End-Stage Renal Disease , 2003, The American journal of the medical sciences.
[12] K. Eagle,et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.
[13] R. Kerber,et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices , 2002 .
[14] R. Kerber,et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.
[15] L. Goldman,et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.
[16] J. Svendsen,et al. Quality assessment of pacemaker implantations in Denmark. , 2002, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[17] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[18] B. Wilkoff,et al. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. , 2001, Current opinion in cardiology.
[19] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[20] R. Shepard,et al. Permanent Pacemaker Infections , 1999 .
[21] N. Powe,et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis. , 1999, Kidney international.
[22] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[23] F. Port,et al. Morbidity and mortality in dialysis patients. , 1994, Kidney international.
[24] W. Hörl,et al. Uremia and infection: mechanisms of impaired cellular host defense. , 1993, Nephron.
[25] D. Hayes,et al. Venous complications after insertion of a transvenous pacemaker. , 1992, Mayo Clinic proceedings.
[26] John A. Walker. Myocardial calcification and cardiac dysfunction in chronic renal failure, by SG Rostand, C Sanders, KA Kirk, EA Rutsky, and RG Fraser. Am J Med 85:651–657, 1988 , 1989 .
[27] R. G. Fraser,et al. Myocardial calcification and cardiac dysfunction in chronic renal failure. , 1988, The American journal of medicine.